Fresenius | FRE - Market Capitalization


Fresenius reported EUR21.03B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 8.42B 1.71B Mar/2026
Alcon AG USD 37.06B 5.98B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BASF EUR 46.77B 7.11B Mar/2026
Bayer EUR 38.69B 2.33B Mar/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
DaVita Healthcare Partners USD 10.27B 2.48B Mar/2026
Demant DKK 46.01B 10.48B Dec/2025
E.ON EUR 49.57B 6.98B Mar/2026
Essilor EUR 125.04B 18.49B Dec/2025
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GN Store Nord DKK 15.22B 890.39M Mar/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Philips EUR 22.47B 96.29M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
RWE EUR 42.9B 9.24B Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Smith & Nephew USD 3.45B 9.87B Jun/2026